| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |